CPT 81422: Cell‑free Fetal DNA Microdeletion Genomic Panel
Commercial payers pay $725 on average nationally for this procedure.
CPT code 81422 describes a genomic sequence analysis panel performed on circulating cell–free fetal DNA from maternal blood to evaluate for fetal chromosomal microdeletions (for example, DiGeorge or Cri–du–chat syndromes); this is a noninvasive prenatal testing service typically categorized as a genetic sequencing panel performed in a clinical laboratory or reference lab setting and ordered as part of prenatal screening or evaluation of suspected fetal chromosomal abnormalities.
For related coverage guidance, see recent payer policy updates: RTM Testing of Homocysteine Metabolism-Related Conditions, Multimarker Serum Testing Related to Ovarian Cancer, Genomic Profiling for Selecting Targeted Cancer Therapies.
Customize your policy alerts
Sign up for cpt 81422 policy alerts
Get alerted when payer policies referencing 81422 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
For CPT 81422 the average commercial benchmark is represented by BUCA at $724.70, with a median of $652.80 and interquartile spread from $472.90 to $879.10. Blue Cross Blue Shield (BCBS) shows the highest dispersion among listed payers: its P75 minus P25 equals $926.60 ($948.80 - $602.20), indicating wide variability in commercial contract rates. Cigna has the next-largest IQR at $660.90 ($1,035.90 - $387.50), while Aetna’s IQR is comparatively narrow at $389.00 ($633.00 - $324.40). UnitedHealth Group’s IQR is $371.30 ($759.10 - $318.80), the tightest among payers listed here.
Mean rates vary notably: BCBS’s mean is $827.10 and Cigna’s is $754.60, both above the BUCA average, while UnitedHealth Group’s mean is $610.90 and Aetna’s is $501.40, below BUCA. The combination of higher means and larger IQRs for BCBS and Cigna suggests more heterogeneous contracting or regional variation, whereas Aetna and UnitedHealth Group present more concentrated commercial rate distributions around their midpoints.